Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5047060> ?p ?o }
Showing triples 1 to 52 of
52
with 100 triples per page.
- Q5047060 subject Q18924462.
- Q5047060 subject Q6580276.
- Q5047060 subject Q8221418.
- Q5047060 subject Q8761830.
- Q5047060 subject Q8808701.
- Q5047060 subject Q8878420.
- Q5047060 abstract "Cartazolate (SQ-65,396) is a drug of the pyrazolopyridine class. It acts as a GABAA receptor positive allosteric modulator at the barbiturate binding site of the complex and has anxiolytic effects in animals. It is also known to act as an adenosine antagonist at the A1 and A2 subtypes and as a phosphodiesterase inhibitor. Cartazolate was tested in human clinical trials and was found to be efficacious for anxiety but was never marketed. It was developed by a team at E.R. Squibb and Sons in the 1970s.".
- Q5047060 atcPrefix "none".
- Q5047060 casNumber "34966-41-1".
- Q5047060 fdaUniiCode "8K93Z46WPY".
- Q5047060 iupacName "ethyl 4-(butylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylate".
- Q5047060 pubchem "37015".
- Q5047060 thumbnail Cartazolate.png?width=300.
- Q5047060 wikiPageWikiLink Q14888579.
- Q5047060 wikiPageWikiLink Q154430.
- Q5047060 wikiPageWikiLink Q18924462.
- Q5047060 wikiPageWikiLink Q190012.
- Q5047060 wikiPageWikiLink Q206348.
- Q5047060 wikiPageWikiLink Q2649417.
- Q5047060 wikiPageWikiLink Q30612.
- Q5047060 wikiPageWikiLink Q410943.
- Q5047060 wikiPageWikiLink Q418251.
- Q5047060 wikiPageWikiLink Q421035.
- Q5047060 wikiPageWikiLink Q4682270.
- Q5047060 wikiPageWikiLink Q5402458.
- Q5047060 wikiPageWikiLink Q5969579.
- Q5047060 wikiPageWikiLink Q60147.
- Q5047060 wikiPageWikiLink Q616005.
- Q5047060 wikiPageWikiLink Q62903.
- Q5047060 wikiPageWikiLink Q6580276.
- Q5047060 wikiPageWikiLink Q7263416.
- Q5047060 wikiPageWikiLink Q7831126.
- Q5047060 wikiPageWikiLink Q8221418.
- Q5047060 wikiPageWikiLink Q8386.
- Q5047060 wikiPageWikiLink Q8761830.
- Q5047060 wikiPageWikiLink Q8808701.
- Q5047060 wikiPageWikiLink Q8878420.
- Q5047060 wikiPageWikiLink Q898387.
- Q5047060 wikiPageWikiLink Q9635.
- Q5047060 atcPrefix "none".
- Q5047060 casNumber "34966".
- Q5047060 iupacName "ethyl 4--1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylate".
- Q5047060 pubchem "37015".
- Q5047060 unii "8".
- Q5047060 type ChemicalSubstance.
- Q5047060 type Drug.
- Q5047060 type ChemicalObject.
- Q5047060 type Thing.
- Q5047060 type Q8386.
- Q5047060 comment "Cartazolate (SQ-65,396) is a drug of the pyrazolopyridine class. It acts as a GABAA receptor positive allosteric modulator at the barbiturate binding site of the complex and has anxiolytic effects in animals. It is also known to act as an adenosine antagonist at the A1 and A2 subtypes and as a phosphodiesterase inhibitor. Cartazolate was tested in human clinical trials and was found to be efficacious for anxiety but was never marketed. It was developed by a team at E.R.".
- Q5047060 label "Cartazolate".
- Q5047060 depiction Cartazolate.png.